Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_assertion type Assertion NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_head.
- NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_assertion description "[To the best of our knowledge, this is the first prospective analysis in which the prognostic impact of a relatively high number of antigenic markers has been simultaneously analyzed in a large series of uniformly treated patients, showing that the expression of several antigens (particularly CD28 and CD117) on bone marrow plasma cells from patients with MM can help to identify patients at high risk of progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_provenance.
- NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_assertion evidence source_evidence_literature NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_provenance.
- NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_assertion SIO_000772 18443352 NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_provenance.
- NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_assertion wasDerivedFrom befree-20140225 NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_provenance.
- NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_assertion wasGeneratedBy ECO_0000203 NP902691.RADxdJ9QBA66MMbqKJQuvVgD2Vna316XegVpiWAV0rMrQ130_provenance.